{"count": 10, "results": [{"_id": "34186538", "pmid": 34186538, "title": "Intrauterine Growth Retardation in Pregnant Women with Long QT Syndrome Treated with Beta-Receptor Blockers.", "journal": "Neonatology", "authors": ["Welzel T", "Donner B", "van den Anker JN"], "date": "2021-01-01T00:00:00Z", "doi": "10.1159/000516845", "meta_date_publication": "2021", "meta_volume": "118", "meta_issue": "4", "meta_pages": "406-415", "score": 50249.742, "text_hl": "@<m>DISEASE_Fetal_Growth_Retardation</m> @DISEASE_MESH:D005317 @@@IUGR@@@, particularly in preterm infants, can result in adverse neonatal outcomes. ", "citations": {"NLM": "Welzel T, Donner B, van den Anker JN. Intrauterine Growth Retardation in Pregnant Women with Long QT Syndrome Treated with Beta-Receptor Blockers. Neonatology. 2021;118(4):406-415. PMID: 34186538", "BibTeX": "@article{34186538, title={Intrauterine Growth Retardation in Pregnant Women with Long QT Syndrome Treated with Beta-Receptor Blockers.}, author={Welzel T and Donner B and van den Anker JN}, journal={Neonatology}, volume={118}, number={4}, pages={406-415}}"}}, {"_id": "12797460", "pmid": 12797460, "title": "Atenolol developmental toxicity: animal-to-human comparisons.", "journal": "Birth Defects Res A Clin Mol Teratol", "authors": ["Tabacova S", "Kimmel CA", "Wall K", "Hansen D"], "date": "2003-03-01T00:00:00Z", "doi": "10.1002/bdra.10011", "meta_date_publication": "2003 Mar", "meta_volume": "67", "meta_issue": "3", "meta_pages": "181-92", "score": 50071.2, "text_hl": "RESULTS: Manifestations of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ prenatal @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@toxicity@@@ (placental changes, @<m>DISEASE_Fetal_Growth_Retardation</m> @DISEASE_MESH:D005317 @@@intrauterine growth retardation@@@ and changes in @DISEASE_Fetal_Diseases @DISEASE_MESH:D005315 @@@fetal@@@ weight in the absence of @DISEASE_Myopathies_Structural_Congenital @DISEASE_MESH:D020914 @@@structural@@@ @DISEASE_Capillary_Malformation_Arteriovenous_Malformation @DISEASE_MESH:C564254 @@@malformations@@@) are similar in the tested animal species (@SPECIES_10116 @@@rats@@@ and @SPECIES_9986 @@@rabbits@@@) and @SPECIES_9606 @@@humans@@@. ", "citations": {"NLM": "Tabacova S, Kimmel CA, Wall K, Hansen D. Atenolol developmental toxicity: animal-to-human comparisons. Birth Defects Res A Clin Mol Teratol. 2003 Mar;67(3):181-92. PMID: 12797460", "BibTeX": "@article{12797460, title={Atenolol developmental toxicity: animal-to-human comparisons.}, author={Tabacova S and Kimmel CA and Wall K and Hansen D}, journal={Birth Defects Res A Clin Mol Teratol}, volume={67}, number={3}, pages={181-92}}"}}, {"_id": "2242456", "pmid": 2242456, "title": "Atenolol in essential hypertension during pregnancy.", "journal": "BMJ", "authors": ["Butters L", "Kennedy S", "Rubin PC"], "date": "1990-09-22T00:00:00Z", "doi": "10.1136/bmj.301.6752.587", "meta_date_publication": "1990 Sep 22", "meta_volume": "301", "meta_issue": "6752", "meta_pages": "587-9", "score": 50066.434, "text_hl": "CONCLUSION: @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ given from the end of the first trimester in @SPECIES_9606 @@@patients@@@ with mild @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ is associated with @<m>DISEASE_Fetal_Growth_Retardation</m> @DISEASE_MESH:D005317 @@@intrauterine growth retardation@@@. ", "citations": {"NLM": "Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ. 1990 Sep 22;301(6752):587-9. PMID: 2242456", "BibTeX": "@article{2242456, title={Atenolol in essential hypertension during pregnancy.}, author={Butters L and Kennedy S and Rubin PC}, journal={BMJ}, volume={301}, number={6752}, pages={587-9}}"}}, {"_id": "10371362", "pmid": 10371362, "title": "Atenolol and fetal growth in pregnancies complicated by hypertension.", "journal": "Am J Hypertens", "authors": ["Lydakis C", "Lip GY", "Beevers M", "Beevers DG"], "date": "1999-06-01T00:00:00Z", "doi": "10.1016/s0895-7061(99)00031-x", "meta_date_publication": "1999 Jun", "meta_volume": "12", "meta_issue": "6", "meta_pages": "541-7", "score": 50065.47, "text_hl": "In conclusion, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ should be avoided in the early stages of pregnancy and given with caution at the later stages, as it is associated with @<m>DISEASE_Fetal_Growth_Retardation</m> @DISEASE_MESH:D005317 @@@fetal growth retardation@@@, which is related to duration of treatment.", "citations": {"NLM": "Lydakis C, Lip GY, Beevers M, Beevers DG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens. 1999 Jun;12(6):541-7. PMID: 10371362", "BibTeX": "@article{10371362, title={Atenolol and fetal growth in pregnancies complicated by hypertension.}, author={Lydakis C and Lip GY and Beevers M and Beevers DG}, journal={Am J Hypertens}, volume={12}, number={6}, pages={541-7}}"}}, {"_id": "27593227", "pmid": 27593227, "title": "Beta-Blockers and Fetal Growth Restriction in Pregnant Women With Cardiovascular Disease.", "journal": "Circ J", "authors": ["Tanaka K", "Tanaka H", "Kamiya C", "Katsuragi S", "Sawada M", "Tsuritani M", "Yoshida M", "Iwanaga N", "Yoshimatsu J", "Ikeda T"], "date": "2016-09-23T00:00:00Z", "doi": "10.1253/circj.CJ-15-0617", "meta_date_publication": "2016 Sep 23", "meta_volume": "80", "meta_issue": "10", "meta_pages": "2221-6", "score": 50056.94, "text_hl": "The beta group included @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ (n=22), @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ (n=12), @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (n=6), and @CHEMICAL_Bisoprolol @CHEMICAL_MESH:D017298 @@@bisoprolol@@@ (n=5), and the individual incidence of @<m>DISEASE_Fetal_Growth_Retardation</m> @DISEASE_MESH:D005317 @@@FGR@@@ with these medications was 36%, 17%, 33%, and 0%, respectively. ", "citations": {"NLM": "Tanaka K, Tanaka H, Kamiya C, Katsuragi S, Sawada M, Tsuritani M, Yoshida M, Iwanaga N, Yoshimatsu J, Ikeda T. Beta-Blockers and Fetal Growth Restriction in Pregnant Women With Cardiovascular Disease. Circ J. 2016 Sep 23;80(10):2221-6. PMID: 27593227", "BibTeX": "@article{27593227, title={Beta-Blockers and Fetal Growth Restriction in Pregnant Women With Cardiovascular Disease.}, author={Tanaka K and Tanaka H and Kamiya C and Katsuragi S and Sawada M and Tsuritani M and Yoshida M and Iwanaga N and Yoshimatsu J and Ikeda T}, journal={Circ J}, volume={80}, number={10}, pages={2221-6}}"}}, {"_id": "15885543", "pmid": 15885543, "title": "[Neonatal outcome after exposure to beta adrenergic blockers late in pregnancy].", "journal": "Arch Pediatr", "authors": ["Cissoko H", "Jonville-Béra AP", "Swortfiguer D", "Giraudeau B", "Autret-Leca E"], "date": "2005-05-01T00:00:00Z", "doi": "10.1016/j.arcped.2005.01.024", "meta_date_publication": "2005 May", "meta_volume": "12", "meta_issue": "5", "meta_pages": "543-7", "score": 50048.29, "text_hl": "The eight newborns who had @<m>DISEASE_Fetal_Growth_Retardation</m> @DISEASE_MESH:D005317 @@@intrauterine growth retardation@@@ were generally more often exposed to @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ than eutrophic newborns. ", "citations": {"NLM": "Cissoko H, Jonville-Béra AP, Swortfiguer D, Giraudeau B, Autret-Leca E. [Neonatal outcome after exposure to beta adrenergic blockers late in pregnancy]. Arch Pediatr. 2005 May;12(5):543-7. PMID: 15885543", "BibTeX": "@article{15885543, title={[Neonatal outcome after exposure to beta adrenergic blockers late in pregnancy].}, author={Cissoko H and Jonville-Béra AP and Swortfiguer D and Giraudeau B and Autret-Leca E}, journal={Arch Pediatr}, volume={12}, number={5}, pages={543-7}}"}}, {"_id": "11800527", "pmid": 11800527, "title": "Drugs in pregnancy. Antihypertensives.", "journal": "Best Pract Res Clin Obstet Gynaecol", "authors": ["Magee LA"], "date": "2001-12-01T00:00:00Z", "doi": "10.1053/beog.2001.0232", "meta_date_publication": "2001 Dec", "meta_volume": "15", "meta_issue": "6", "meta_pages": "827-45", "score": 50044.438, "text_hl": "@CHEMICAL_Methyldopa @CHEMICAL_MESH:D008750 @@@Methyldopa@@@ and beta-blockers have been used most extensively, although @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ may impair fetal growth in particular and should be avoided.", "citations": {"NLM": "Magee LA. Drugs in pregnancy. Antihypertensives. Best Pract Res Clin Obstet Gynaecol. 2001 Dec;15(6):827-45. PMID: 11800527", "BibTeX": "@article{11800527, title={Drugs in pregnancy. Antihypertensives.}, author={Magee LA}, journal={Best Pract Res Clin Obstet Gynaecol}, volume={15}, number={6}, pages={827-45}}"}}, {"_id": "31665811", "pmid": 31665811, "pmcid": "PMC6911010", "title": "Postnatal beta2 adrenergic treatment improves insulin sensitivity in lambs with IUGR but not persistent defects in pancreatic islets or skeletal muscle", "journal": "J Physiol", "authors": ["Yates DT", "Camacho LE", "Kelly AC", "Steyn LV", "Davis MA", "Antolic AT", "Anderson MJ", "Goyal R", "Allen RE", "Papas KK", "Hay WW Jr", "Limesand SW"], "date": "2019-12-01T00:00:00Z", "doi": "10.1113/JP278726", "meta_date_publication": "2019 Dec", "meta_volume": "597", "meta_issue": "24", "meta_pages": "5835-5858", "score": 50042.14, "text_hl": "Growth, @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@-stimulated @GENE_LOC105613195 @GENE_105613195 @@@insulin@@@ secretion (GSIS) and @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ utilization rates (GURs) were measured in control lambs, @<m>DISEASE_Fetal_Growth_Retardation</m> @DISEASE_MESH:D005317 @@@IUGR@@@ lambs and @<m>DISEASE_Fetal_Growth_Retardation</m> @DISEASE_MESH:D005317 @@@IUGR@@@ lambs treated with adrenergic receptor modifiers: @CHEMICAL_Clenbuterol @CHEMICAL_MESH:D002976 @@@clenbuterol@@@ @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_3_(2_ethylphenoxy)_1_(1_2_3_4_tetrahydronaphth_1_ylamino)_2_propanol_oxalate @CHEMICAL_MESH:C097869 @@@SR59230A@@@ (@<m>DISEASE_Fetal_Growth_Retardation</m> @DISEASE_MESH:D005317 @@@IUGR@@@-@DISEASE_Androgen_Insensitivity_Syndrome @DISEASE_MESH:D013734 @@@AR@@@). ", "citations": {"NLM": "Yates DT, Camacho LE, Kelly AC, Steyn LV, Davis MA, Antolic AT, Anderson MJ, Goyal R, Allen RE, Papas KK, Hay WW Jr, Limesand SW. Postnatal beta2 adrenergic treatment improves insulin sensitivity in lambs with IUGR but not persistent defects in pancreatic islets or skeletal muscle J Physiol. 2019 Dec;597(24):5835-5858. PMID: 31665811", "BibTeX": "@article{31665811, title={Postnatal beta2 adrenergic treatment improves insulin sensitivity in lambs with IUGR but not persistent defects in pancreatic islets or skeletal muscle}, author={Yates DT and Camacho LE and Kelly AC and Steyn LV and Davis MA and Antolic AT and Anderson MJ and Goyal R and Allen RE and Papas KK and Hay WW Jr and Limesand SW}, journal={J Physiol}, volume={597}, number={24}, pages={5835-5858}}"}}, {"_id": "23159698", "pmid": 23159698, "title": "Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes.", "journal": "Am J Obstet Gynecol", "authors": ["Orbach H", "Matok I", "Gorodischer R", "Sheiner E", "Daniel S", "Wiznitzer A", "Koren G", "Levy A"], "date": "2013-04-01T00:00:00Z", "doi": "10.1016/j.ajog.2012.11.011", "meta_date_publication": "2013 Apr", "meta_volume": "208", "meta_issue": "4", "meta_pages": "301.e1-6", "score": 50039.76, "text_hl": "RESULTS: During the study period, 100,029 deliveries occurred; of those, 1964 pregnant @SPECIES_9606 @@@women@@@ experienced @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@chronic hypertension@@@, and 620 neonates (0.6%) were exposed to at least 1 antihypertensive medication (@CHEMICAL_Methyldopa @CHEMICAL_MESH:D008750 @@@methyldopa@@@ or @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@) during pregnancy. ", "citations": {"NLM": "Orbach H, Matok I, Gorodischer R, Sheiner E, Daniel S, Wiznitzer A, Koren G, Levy A. Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol. 2013 Apr;208(4):301.e1-6. PMID: 23159698", "BibTeX": "@article{23159698, title={Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes.}, author={Orbach H and Matok I and Gorodischer R and Sheiner E and Daniel S and Wiznitzer A and Koren G and Levy A}, journal={Am J Obstet Gynecol}, volume={208}, number={4}, pages={301.e1-6}}"}}, {"_id": "11094241", "pmid": 11094241, "title": "Management of mild chronic hypertension during pregnancy: a review.", "journal": "Obstet Gynecol", "authors": ["Ferrer RL", "Sibai BM", "Mulrow CD", "Chiquette E", "Stevens KR", "Cornell J"], "date": "2000-11-01T00:00:00Z", "doi": "10.1016/s0029-7844(00)00938-8", "meta_date_publication": "2000 Nov", "meta_volume": "96", "meta_issue": "5 Pt 2", "meta_pages": "849-60", "score": 50035.516, "text_hl": "Possible adverse effects were @DISEASE_Renal_Insufficiency @DISEASE_MESH:D051437 @@@fetal renal failure@@@ when angiotensin-converting enzyme inhibitors are used in the second or third trimester and @<m>DISEASE_Fetal_Growth_Retardation</m> @DISEASE_MESH:D005317 @@@growth restriction@@@ when @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ is used early in pregnancy. ", "citations": {"NLM": "Ferrer RL, Sibai BM, Mulrow CD, Chiquette E, Stevens KR, Cornell J. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol. 2000 Nov;96(5 Pt 2):849-60. PMID: 11094241", "BibTeX": "@article{11094241, title={Management of mild chronic hypertension during pregnancy: a review.}, author={Ferrer RL and Sibai BM and Mulrow CD and Chiquette E and Stevens KR and Cornell J}, journal={Obstet Gynecol}, volume={96}, number={5 Pt 2}, pages={849-60}}"}}]}